UNSPSC 51461524: Hydrastis

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifiers ZW3Z11D0JV (root) and R763EBH88T (whole), which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 18781 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Ranunculanae, Order Ranunculales, Family Ranunculaceae, Genus Hydrastis L., Species Hydrastis canadensis L., commonly known as GOLDENSEAL or, as here, HYDRASTIS (canadensis).

UNSPSC 51461524 Hydrastis, a Commodity code, covers generic multi-source pharmaceuticals and over-the-counter (OTC) products supplied to state and local government facilities through cooperative purchasing agreements. State and local procurement bodies use this code to source manufactured pharmaceutical products meeting FDA compliance, current Good Manufacturing Practices (cGMP), and Drug Supply Chain Security Act (DSCSA) requirements for distribution across participating jurisdictions. The issuing bodies are multistate cooperative purchasing alliances administering pharmaceutical contracts on behalf of member state departments, local government facilities, and participating states. Vendors must maintain relationships with authorized pharmaceutical wholesalers, provide detailed product specification data (National Drug Codes, SKUs, UPCs, generic descriptions, strength, dosage form, packaging, and manufacturing location), and offer pricing flexibility through flat price, net price formats, or WAC-minus structures.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The contract covers participating state and local government facilities, including Oregon, with awarded vendors provided to authorized wholesalers (AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) by May 15, 2026 and resulting agreements effective July 1, 2026. Evaluation weighs price competitiveness at 75 percent, fixed pricing for the contract term at 10 percent, compliance with data format requirements at 5 percent, EDI capability at 5 percent, and agreement to a 3 percent administrative fee at 5 percent. The contract term is two years for new responders with optional MMCAP extensions, while incumbent responder amendments align with existing expiration dates through June 30, 2028.